查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1371938

到 2030 年静脉液市场预测：按类型、成分、解决方案类型、袋类型、用途、最终用户和地区进行的全球分析

Intravenous Solutions Market Forecasts to 2030 - Global Analysis By Type, Composition, Solution Type, Bag Type, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球静脉注射解决方案市场规模为 130.9 亿美元，预计在预测期内年复合成长率为 10.0%，到 2030 年将达到 255 亿美元。

静脉输液，也称为静脉输液，是透过静脉导管注射到患者静脉中的无菌液体治疗剂。静脉输液用于恢復和维持患者的液体和电解质平衡，特别是当口服摄取不足或需要快速吸收时。透过将必要的液体和药物直接输送到血液中，它可以确保在从医院到门诊病人的各种临床环境中提供有效的治疗和患者支持。

根据2020年美国肠外和经肠营养学会（ASPEN）指南，对于无法接受早期胃肠道营养的高风险患者，应儘早开始经肠营养。

输液新进展

已经开发出具有改进的稳定性、溶解度和生物利用度的专用製剂。此外，现代组件技术使得静脉注射解决方案的产生成为可能，能够提供更多种类的治疗剂，包括复杂的药物和营养素。由于新兴市场的开拓，治疗效果的提高使得治疗更广泛的医学疾病成为可能，市场基础也扩大了。因此，静脉输液市场受益于更先进和专业的解决方案的可用性，这些解决方案改善了患者照护和治疗结果，显着促进了市场成长。

高成本

静脉注射製剂可能很昂贵，特别是如果它们使用复杂的成分或专门的製剂。此外，製造、包装和品管价格也会影响输液的总成本。因此，这种定价可能会限制市场准入，特别是在资源有限或医疗保健基础设施薄弱的地区。

提高认识

随着人们健康意愿的增强，对预防性和整体保健方法的需求不断增加。静脉输液不仅是为了医疗目的，也是为了健康和活力。它经常用于供给、免疫支持和营养供给。此外，客製化静脉注射疗法作为减少缺陷、增加能量和改善整体健康的一种方式越来越受欢迎。此外，诊所和提供者正在提供静脉注射解决方案，以满足意愿健康的一代人的健康和表现目标，这正在推动市场规模。

缺乏标准化和品质

产品性能和品质的一致性对于病患安全至关重要，但可能会受到各种品质和安全标准的阻碍。此外，各地区缺乏统一的法规导致製造实务和产品标籤存在差异，这使得医疗保健专业人员在确保静脉输液的可靠性方面面临挑战。因此，缺乏标准化和法律规范导致市场风险和复杂性增加，需要全面的、全球认可的标准来确保这些重要医疗产品的安全性和有效性，这强调了指南的必要性。

COVID-19 的影响

静脉输液市场受到 COVID-19 爆发的严重负面影响。医疗机构面临罕见的资源紧张，而且常常负担过重。这导致了寻找和分配这些重要医疗输液的短缺和后勤困难。此外，经济危机和不确定性阻碍了医疗保健产业的投资。因此，儘管需求增加，但大流行给静脉输液市场带来了物流和财务挑战，对可用性和供应产生了负面影响。

预计葡聚醣细分市场在预测期内将是最大的细分市场

据估计，右旋糖酐领域在医疗机构中占据最大份额，因为它主要用于促进血液流动并减少手术和其他医疗程序期间形成血栓的可能性。此外，这些基于葡聚醣的静脉注射溶液可作为血浆扩张剂，促进血液循环并帮助维持血压。这些对于患者出血或需要血流动力学支持的情况至关重要。因此，基于葡聚醣的静脉注射液已成为医疗保健领域更大的静脉注射液市场的重要组成部分，因为它们对于在医疗活动期间维持患者的健康至关重要。

大容量箱包领域预计在预测期间内年复合成长率最高

预计大容量箱包市场在预测期内的年复合成长率最高。这些袋子在医疗保健领域的多种用途中是不可或缺的，包括营养输送、给药和供给。此外，医院、诊所和其他医疗机构经常使用大容量输液袋，为患者提供有效且受控的静脉治疗。大容量输液袋是医疗保健产业静脉注射解决方案市场的支柱，因为它们可以灵活地容纳不同类型的输液，这对于需要长期治疗的患者尤其重要。

比最大的地区

由于医疗保健系统中庞大的患者群体、重要参与者的崛起、药物的容易获得、医疗保健系统的复杂性以及有利的报销做法，欧洲在预测期内获得了最大的市场占有率。此外，由于政府对国民医疗服务和健康保险的支持以及该行业的技术进步，欧洲静脉输液市场可能会发展。而且，英国静脉输液市场市场占有率最高，法国静脉输液市场在欧洲大陆扩张最快。

复合年复合成长率最高的地区：

由于快速成长，预计亚太地区在预测期内复合年复合成长率最高。这是由于公共和私营部门对研究的大量投资，以及技术开发、医疗保健行业和大学等各相关人员之间加强的合作。因此，不健康的食品消费模式导致的慢性病患病上升以及对具有成本效益的护理选择的增加是预计推动亚太地区市场成长的两个关键要素。

提供免费客製化：

订阅此报告的客户可以存取以下免费自订选项之一：

  • 公司简介
    • 其他市场参与者的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计、预测和年复合成长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第1章执行摘要

第2章前言

  • 概述
  • 利害关係人
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 调查来源
    • 主要调查来源
    • 二次调查来源
    • 先决条件

第3章市场趋势分析

  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 应用分析
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第5章全球输液解决方案市场：按类型

  • 完全肠外营养
  • 部分肠外营养

第6章全球静脉注射药物市场：依结构

  • 碳水化合物
  • 维生素和矿物质
  • 肠外脂肪乳剂
  • 单给药胺基酸
  • 其他结构

第7章全球输液解决方案市场：依解决方案类型

  • 葡聚醣
  • 生理食盐水
  • 高渗透压盐水
  • 胺基酸
  • 生理食盐水
  • 乳酸林格氏液
  • 肝素和微量元素
  • 维生素和矿物质
  • 混合溶液

第8章全球静脉药品市场：按袋类型

  • 大容量袋
  • 小容量袋

第9章全球输液解决方案市场：依应用分类

  • 营养滴注液
  • 输血
  • 基本静脉注射液
  • 灌输液
  • 药物滴注液

第10章全球输液解决方案市场：依最终用户分类

  • 诊所
  • 医院
  • 门诊手术中心
  • 家庭护理设置

第11章全球输液解决方案市场：按地区

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 其他中东和非洲

第12章进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第13章公司简介

  • ICU Medical, Inc.
  • B. Braun Melsungen Ag
  • JW Life Science
  • Baxter International Inc.
  • Fresenius Kabi USA, LLC
  • Vifor Pharma Management Ltd
  • Amanta Healthcare
  • Grifols, SA
  • Salius Pharma Private Limited.
  • Pfizer, Inc.
  • Axa Parenterals Ltd
  • Ajinomoto Co., Inc.
  • Otsuka Pharmaceutical Co., Ltd
  • Sichuan Kelun Pharmaceutical Co Ltd
  • Soxa Formulations & Research Pvt. Ltd
  • Braun Melsungen AG
Product Code: SMRC23995

According to Stratistics MRC, the Global Intravenous Solutions Market is accounted for $13.09 billion in 2023 and is expected to reach $25.5 billion by 2030 growing at a CAGR of 10.0 % during the forecast period. Intravenous solutions, also called IV solutions, are sterile liquid treatments that are injected into a patient's veins by means of an intravenous line. These treatments are used for a variety of essential medical functions, such as rehydration, medicine delivery, and nutritional support, IV solutions are used to restore and maintain a patient's fluid and electrolyte balance, particularly when oral intake is insufficient or rapid absorption is required. They are composed of a precisely balanced blend of water, nutrients, and sometimes drugs and are a crucial part of contemporary healthcare, guaranteeing efficient treatment and patient support in a range of clinical settings, from hospitals to outpatient care, by supplying necessary fluids and medicinal chemicals straight into the bloodstream.

According to the guidelines by American Society for Parenteral and Enteral Nutrition (ASPEN), in 2020, the early parenteral nutrition should be initiated as soon as possible in the high-risk patient for whom early gastric enteral nutrition is not feasible.

Market Dynamics:

Driver:

New developments in IV solutions

As the developments involve the creation of specialized formulations with improved stability, solubility, and bioavailability. Additionally, modern ingredient technology makes it possible to create intravenous solutions that can transport a wider variety of therapeutic agents, such as complicated drugs and nutrients. As a result of these developments, it is now possible to treat a wider range of medical diseases by improving treatment efficacy and broadening the market's capacities. Therefore, the market for intravenous solutions benefits from being able to provide more sophisticated and specialized solutions, which enhance patient care and treatment outcomes and thus significantly drives the market growth.

Restraint:

High cost

IV solutions can be pricey, especially when made with complicated ingredients or in specialist formulations. Moreover, the price of manufacturing, packaging, and quality control can affect the overall cost of IV solutions. Hence, this pricing aspect may restrict market access, particularly in areas with limited resources or poor healthcare infrastructure.

Opportunity:

Increase in awareness

Preventive and holistic healthcare methods are in greater demand as people grow more health-conscious. Intravenous solutions are in demand not just for medical treatment but also for wellness and vitality reasons. They are frequently used for rehydration, immunological support, and nutrient supplementation. Furthermore, customized IV therapy is becoming more and more popular as a way to reduce deficiencies, increase energy, and improve general wellbeing. Moreover, clinics and providers offer intravenous solutions that meet the wellness and performance objectives of a health-conscious generation, which thus propel the market size.

Threat:

Lack of standardization and quality

The consistency of product performance and quality, which is essential for patient safety, might be hampered by varying quality and safety standards. Moreover, the absence of unified regulations across regions can lead to disparities in manufacturing practices and product labeling, making it challenging for healthcare providers to ensure the reliability of intravenous solutions. Therefore, this lack of standardization and regulatory oversight can result in increased risks and complexities in the market, emphasizing the need for comprehensive, globally recognized guidelines to ensure the safety and efficacy of these critical medical products.

COVID-19 Impact

The market for intravenous solutions was significantly negatively impacted by the COVID-19 epidemic. Healthcare facilities experienced rare resource pressures and were frequently overburdened, which resulted in shortages and logistical difficulties when locating and dispensing these vital medical fluids. Additionally, investments in the healthcare industry were impeded by the economic collapse and uncertainties. Therefore, despite rising demand, the pandemic posed logistical and financial challenges for the market for intravenous solutions, adversely impacting both accessibility and supply.

The Dextran segment is expected to be the largest during the forecast period

The Dextran segment is estimated to hold the largest share, as these treatments are used in healthcare facilities to boost blood flow and lower the chance of clot formation, primarily during operations and other medical procedures. Additionally, these IV solutions based on dextran, function as plasma expanders, enhancing circulation and assisting in blood pressure maintenance. They are crucial in circumstances where patients can experience bleeding or need hemodynamic support. Thus, intravenous solutions based on dextran are an essential part of the larger intravenous solutions market in the healthcare sector since they are essential in sustaining patient wellbeing during medical operations.

The large volume bags segment is expected to have the highest CAGR during the forecast period

The large volume bags segment is anticipated to have highest CAGR during the forecast period, due to a variety of uses in healthcare, such as nutrient delivery, medicine administration, and hydration, these bags are essential. Moreover, in hospitals, clinics, and other medical facilities, large-volume bags are frequently utilized to deliver effective and controlled intravenous therapy to patients. Hence, they are a backbone of the intravenous solutions market in the healthcare industry because they are flexible in accepting different types of solutions and are especially important for patients needing prolonged treatments.

Region with largest share:

Europe commanded the largest market share during the extrapolated period owing to the healthcare system's enormous patient population, the prominence of important players, the accessibility of drugs, the sophistication of the healthcare systems, and the advantageous reimbursement practices. Furthermore, the market for intravenous (IV) solutions in Europe will probably develop as a result of government support for the National Health Service and health insurance as well as industry technological advancements. Additionally, the intravenous solution market in the United Kingdom had the highest market share, while the intravenous solution market in France had the quickest rate of expansion in the continent of Europe.

Region with highest CAGR:

Asia Pacific is expected to witness highest CAGR over the projection period, owing to rapid growth, which can be attributed to the high investment made in research by both public and private entities, as well as technological developments and an increase in the number of cooperative relationships between different stakeholders, including the healthcare industry, universities, and others. Therefore, the rising prevalence of chronic diseases brought on by unhealthy food consumption patterns and the growing choice for cost-effective care are two significant factors that are projected to propel market growth in the Asia Pacific region.

Key players in the market:

Some of the key players in the Intravenous Solutions Market include: ICU Medical, Inc., B. Braun Melsungen Ag, JW Life Science, Baxter International Inc., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, Amanta Healthcare, Grifols, S.A, Salius Pharma Private Limited., Pfizer, Inc., Axa Parenterals Ltd, Ajinomoto Co., Inc., Otsuka Pharmaceutical Co., Ltd, Sichuan Kelun Pharmaceutical Co Ltd, Soxa Formulations & Research Pvt. Ltd and Braun Melsungen AG.

Key Developments:

In March 2022, Otsuka Pharmaceutical received regulatory approval in Japan for the sale of SAMTASU intravenous infusion for treating cardiac edema.

In February 2022, B. Braun Medical received the US FDA approval to begin operations at its new IV saline solution manufacturing facility in Daytona Beach, Florida.

In September 2021, B. Braun Medical Inc. launched CARESAFE IV Administration Sets with an Optional AirStop component.

In July 2021, Grifols S.A. announced the establishment of an intravenous (IV) solutions production plant in Nigeria.

Types Covered:

  • Total Parenteral Nutrition
  • Partial Parenteral Nutrition

Compositions Covered:

  • Carbohydrates
  • Vitamins and Minerals
  • Parenteral Lipid Emulsion
  • Single Dose Amino Acids
  • Other Compositions

Solution Types Covered:

  • Dextran
  • Saline
  • Hypertonic Saline
  • Amino Acid
  • Normal Saline
  • Lactated Ringer's
  • Heparin And Trace Elements
  • Vitamins & Minerals
  • Mixed Solutions

Bag Types Covered:

  • Large Volume Bags
  • Small Volume Bags

Applications Covered:

  • Nutritional IV Solution
  • Blood IV Solution
  • Basic IV Solution
  • Irrigation IV Solution
  • Drug IV Solution

End Users Covered:

  • Clinics
  • Hospital
  • Ambulatory Surgery Centers
  • Home Care Settings

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact Of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Intravenous Solutions Market, By Type

  • 5.1 Introduction
  • 5.2 Total Parenteral Nutrition
  • 5.3 Partial Parenteral Nutrition

6 Global Intravenous Solutions Market, By Composition

  • 6.1 Introduction
  • 6.2 Carbohydrates
  • 6.3 Vitamins And Minerals
  • 6.4 Parenteral Lipid Emulsion
  • 6.5 Single Dose Amino Acids
  • 6.6 Other Compositions

7 Global Intravenous Solutions Market, By Solution Type

  • 7.1 Introduction
  • 7.2 Dextran
  • 7.3 Saline
  • 7.4 Hypertonic Saline
  • 7.5 Amino Acid
  • 7.6 Normal Saline
  • 7.7 Lactated Ringer's
  • 7.8 Heparin And Trace Elements
  • 7.9 Vitamins & Minerals
  • 7.1 Mixed Solutions

8 Global Intravenous Solutions Market, By Bag Type

  • 8.1 Introduction
  • 8.2 Large Volume Bags
  • 8.3 Small Volume Bags

9 Global Intravenous Solutions Market, By Application

  • 9.1 Introduction
  • 9.2 Nutritional IV Solution
  • 9.3 Blood IV Solution
  • 9.4 Basic IV Solution
  • 9.5 Irrigation IV Solution
  • 9.6 Drug IV Solution

10 Global Intravenous Solutions Market, By End User

  • 10.1 Introduction
  • 10.2 Clinics
  • 10.3 Hospital
  • 10.4 Ambulatory Surgery Centers
  • 10.5 Home Care Settings

11 Global Intravenous Solutions Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 ICU Medical, Inc.
  • 13.2 B. Braun Melsungen Ag
  • 13.3 JW Life Science
  • 13.4 Baxter International Inc.
  • 13.5 Fresenius Kabi USA, LLC
  • 13.6 Vifor Pharma Management Ltd
  • 13.7 Amanta Healthcare
  • 13.8 Grifols, S.A
  • 13.9 Salius Pharma Private Limited.
  • 13.10 Pfizer, Inc.
  • 13.11 Axa Parenterals Ltd
  • 13.12 Ajinomoto Co., Inc.
  • 13.13 Otsuka Pharmaceutical Co., Ltd
  • 13.14 Sichuan Kelun Pharmaceutical Co Ltd
  • 13.15 Soxa Formulations & Research Pvt. Ltd
  • 13.16 Braun Melsungen AG

List of Tables

  • Table 1 Global Intravenous Solutions Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Intravenous Solutions Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Intravenous Solutions Market Outlook, By Total Parenteral Nutrition (2021-2030) ($MN)
  • Table 4 Global Intravenous Solutions Market Outlook, By Partial Parenteral Nutrition (2021-2030) ($MN)
  • Table 5 Global Intravenous Solutions Market Outlook, By Composition (2021-2030) ($MN)
  • Table 6 Global Intravenous Solutions Market Outlook, By Carbohydrates (2021-2030) ($MN)
  • Table 7 Global Intravenous Solutions Market Outlook, By Vitamins And Minerals (2021-2030) ($MN)
  • Table 8 Global Intravenous Solutions Market Outlook, By Parenteral Lipid Emulsion (2021-2030) ($MN)
  • Table 9 Global Intravenous Solutions Market Outlook, By Single Dose Amino Acids (2021-2030) ($MN)
  • Table 10 Global Intravenous Solutions Market Outlook, By Other Compositions (2021-2030) ($MN)
  • Table 11 Global Intravenous Solutions Market Outlook, By Solution Type (2021-2030) ($MN)
  • Table 12 Global Intravenous Solutions Market Outlook, By Dextran (2021-2030) ($MN)
  • Table 13 Global Intravenous Solutions Market Outlook, By Saline (2021-2030) ($MN)
  • Table 14 Global Intravenous Solutions Market Outlook, By Hypertonic Saline (2021-2030) ($MN)
  • Table 15 Global Intravenous Solutions Market Outlook, By Amino Acid (2021-2030) ($MN)
  • Table 16 Global Intravenous Solutions Market Outlook, By Normal Saline (2021-2030) ($MN)
  • Table 17 Global Intravenous Solutions Market Outlook, By Lactated Ringer's (2021-2030) ($MN)
  • Table 18 Global Intravenous Solutions Market Outlook, By Heparin And Trace Elements (2021-2030) ($MN)
  • Table 19 Global Intravenous Solutions Market Outlook, By Vitamins & Minerals (2021-2030) ($MN)
  • Table 20 Global Intravenous Solutions Market Outlook, By Mixed Solutions (2021-2030) ($MN)
  • Table 21 Global Intravenous Solutions Market Outlook, By Bag Type (2021-2030) ($MN)
  • Table 22 Global Intravenous Solutions Market Outlook, By Large Volume Bags (2021-2030) ($MN)
  • Table 23 Global Intravenous Solutions Market Outlook, By Small Volume Bags (2021-2030) ($MN)
  • Table 24 Global Intravenous Solutions Market Outlook, By Application (2021-2030) ($MN)
  • Table 25 Global Intravenous Solutions Market Outlook, By Nutritional IV Solution (2021-2030) ($MN)
  • Table 26 Global Intravenous Solutions Market Outlook, By Blood IV Solution (2021-2030) ($MN)
  • Table 27 Global Intravenous Solutions Market Outlook, By Basic IV Solution (2021-2030) ($MN)
  • Table 28 Global Intravenous Solutions Market Outlook, By Irrigation IV Solution (2021-2030) ($MN)
  • Table 29 Global Intravenous Solutions Market Outlook, By Drug IV Solution (2021-2030) ($MN)
  • Table 30 Global Intravenous Solutions Market Outlook, By End User (2021-2030) ($MN)
  • Table 31 Global Intravenous Solutions Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 32 Global Intravenous Solutions Market Outlook, By Hospital (2021-2030) ($MN)
  • Table 33 Global Intravenous Solutions Market Outlook, By Ambulatory Surgery Centers (2021-2030) ($MN)
  • Table 34 Global Intravenous Solutions Market Outlook, By Home Care Settings (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.